Prudential Financial Inc Vbi Vaccines Inc Transaction History

Prudential Financial Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.29 - $0.64 $18,560 - $40,960	-64,000 Reduced 85.45%	10,895 $3,000
Q4 2022 Feb 14, 2023	SELL	$0.38 - $22.5 $950 - $56,250	-2,500 Reduced 3.23%	74,895 $0
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $43,890 - $120,365	66,500 Added 610.37%	77,395 $63,000
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $2,839 - $4,137	-1,285 Reduced 10.55%	10,895 $25,000
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $25,690 - $34,131	-9,175 Reduced 42.96%	12,180 $38,000
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $28,984 - $46,307	11,105 Added 108.34%	21,355 $72,000
Q1 2021 May 12, 2021	SELL	$2.91 - $4.32 $116 - $172	-40 Reduced 0.39%	10,250 $32,000
Q4 2020 Feb 16, 2021	BUY	$2.15 - $3.5 $387 - $630	180 Added 1.78%	10,290 $28,000
Q2 2020 Aug 12, 2020	SELL	$0.87 - $3.13 $1,766 - $6,353	-2,030 Reduced 16.72%	10,110 $31,000
Q4 2019 Feb 11, 2020	BUY	$0.48 - $1.38 $820 - $2,359	1,710 Added 16.4%	12,140 $16,000
Q3 2019 Nov 13, 2019	SELL	$0.47 - $1.05 $488 - $1,092	-1,040 Reduced 9.07%	10,430 $4,000
Q2 2019 Aug 08, 2019	BUY	$0.65 - $2.12 $7,455 - $24,316	11,470 New	11,470 $0

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.